Company Profile (AI Text)
Name: LifeBridge Innovations, PBC
Canonical URL: https://wefunder.com/LifeBridgeinnovations
Updated at: 2026-06-17T05:01:36Z

Tagline: Transforming metastatic cancer from a terminal prognosis to a manageable disease like diabetes
Elevator pitch: When people with cancer get really sick all known medicines stop working and they are told to prepare to die. We are going to change that by building a device just for them. The device makes a therapy proven to work in patients with cancer in just one location, like the lungs, work in more than one location like the lung and liver at the same time. Best of all it treats cancer without making the patients feel sick or tired and they don't lose their hair.

Key claims:
- Total raised on Wefunder: 368836 | citation: https://wefunder.com/LifeBridgeinnovations#claim-total-raised
- Total investors: 217 | citation: https://wefunder.com/LifeBridgeinnovations#claim-total-investors

Verified facts:
- Total raised on Wefunder: 368836 | observed_at: 2026-06-17T05:01:36Z | expires_at: 2026-06-18T05:01:36Z
- Total investors: 217 | observed_at: 2026-06-17T05:01:36Z | expires_at: 2026-06-18T05:01:36Z

Computed metrics:
- total_amount_raised: 368836
- total_investors: 217
- team_size: 10
- featured_investor_count: 7
- faq_count: 5
- recent_post_count: 0

Quick facts:
- Team has 60 devices through FDA, products in 3000 hospitals, 300 yrs combined experience | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-1
- Med tech firm sent unsolicited offer to buy us -investor/team unanimously agreed too early to sell | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-2
- Granted patents in U.S., Canada, MX, EU, Japan, China, Australia, New Zealand, India, Chile | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-3
- $5M raised from friends & family, angels, who know our track record & see a huge market opportunity | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-4
- TTF is based on 25 years of proven research. Fixed form approved by the FDA for multiple indications | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-5
- On any given day, over 500,000 U.S. patients in their last 36months could benefit from our therapy | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-6
- TTF has minimal side effects: no hair loss, no nausea, no fatigue, no chemo brain, etc. | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-7
- Committed to serve those who cannot afford it while maintaining industry benchmarked profitability | citation: https://wefunder.com/LifeBridgeinnovations#claim-fact-8

FAQ:
- Q: Lifebridge team, you have grabbed my attention today! Do you see - as part of your planned clinical trials, to combine your TTF product with drug therapies that minimizes/eliminates metastasis? I can see this combination as a powerful winning combo.
  A: Hello Kirtson, thank you for your insightful question. We are keeping our eye on new drug therapies that reduce metastases without compromising the immune system. To date most of the TTF used in clinical trials has been in combination with powerful chemo's that often compromise the immune system. What research has documented is that there is a correlation between immune system health and the effectiveness of TTF. One of the main mechanisms of TTF is that it causes cancer cells to produce malf...
- Q: It seems much of the future potential is based on Novocure patents expiring in the next few years. Can you clarify if these are fixed term patents that cannot be renewed? If not I would assume they will pay the necessary fees to renew.
  A: Hello Jennifer, thank you for this important question. All the patents in question are fixed term. They cannot be renewed. Patent terms are for 20 years. The first day in the life of a patent is called the "Priority Date". Most of the patents in question have Priority Dates between 2000 and 2002. Sometimes, patents can be extended because the patent office took longer than allowed to do their work. So, if they took 6 months too long, the patent life is given another 6 months. Sometimes new pa...
- Q: Hi, you have proposed a 19.5M valuation cap. Could you please share the valuation and terms of Novocure’s buyout offer?
  A: Hello David, Thank you for your question. We have not disclosed which larger company sent us an offer, and the terms of the offer are under NDA.
- Q: How can an oncologist obtain information on how this can be used with her patients? What is the cost for the patient and if it can be covered by insurance? How can the creators be contacted? Thank you
  A: Hello Lissette, thank you for your question. We are preparing our device for a pilot clinical trial and then a pivotal trial for final approval. Our device is not yet available for prescriping. TTF is available through Novocure for GBM brain cancer, and Mesotheloma. Your Oncologist can find out more through www.novocure.com
- Q: HI team, Great job with progress and the raise so far. Definitely a revolutionary product. Got a few questions before finalizing the investment. 1. Is your device currently in use or still in trail for final approval? 2. If in use, how many devices have been sold? If in trail,...
  A: Hello Arul, thank you for your pertinent questions. Please see the following replies and let me know if you have additional questions. 1. Arul: Is your device currently in use or still in trial for final approval? Peter: We are currently in the FDA approval process. The FDA has approved our clinical trial protocol, allowing us to treat up to 36 patients across 10 different types of cancer in a single basket trial. This approach saves years of research and millions of dollars, compared to runn...